Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of...

Area of Science:

• Microbiology
• Immunology
• Vaccine Development

Background:

• Acinetobacter baumannii is a growing global health threat due to multi-drug and pan-drug resistance.
• Antimicrobial resistance necessitates novel strategies, including vaccine development against resistant pathogens.

Purpose of the Study:

• To develop and compare different methods for preparing Acinetobacter baumannii outer membrane vesicles (AbOMVs) as vaccine candidates.
• To evaluate the protective efficacy of various AbOMV preparations against Acinetobacter baumannii infection in a mouse model.

Main Methods:

• Three distinct AbOMV preparation methods were employed: spontaneously released (sOMV), sucrose-extracted (SuOMV), and native (nOMV).
• AbOMVs were characterized based on yield, particle size, protein content, and LPS/DNA levels.
• Mice were immunized intramuscularly or intranasally with each AbOMV type and challenged with Acinetobacter baumannii.

Main Results:

• The three AbOMV types differed significantly in their yield, particle size, protein composition, and LPS/DNA content.
• Both intramuscular and intranasal vaccination routes provided significant protection against lethal and sub-lethal Acinetobacter baumannii challenge.
• Intranasal vaccination induced a more robust immune response, potentially due to increased mucosal sIgA.
• Sucrose-extracted AbOMVs (SuOMV) elicited the strongest protective immunity, indicated by high specific serum IgG and mucosal sIgA levels.

Conclusions:

• The method of AbOMV preparation significantly influences their characteristics and subsequent protective efficacy.
• Sucrose-extracted AbOMVs represent a promising candidate for developing effective vaccines against Acinetobacter baumannii infections.
• Vaccination strategies, particularly intranasal delivery, can enhance protection against this challenging pathogen.